Medical journal accused by GSK8th June 2007
The head of a UK-based pharmaceutical group has criticised a leading medical journal for â€śmixing science with politicsâ€? in publishing articles attacking its diabetes drug Avandia.
Jean-Pierre Garnier, chief executive of GlaxoSmithKline, criticised New England Journal of Medicine papers raising safety concerns with Avandia which he said were â€śsmearing the drug.â€? As the GSK share price continued to fall, he was speaking as GSK mounted a fresh defence on the safety of Avandia during hearings in Washington triggered by the NEJMâ€™s article last month suggesting an increased risk of heart attack associated with the drug.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Medical journal accused by GSK
Author: Mark Nicholls
Article Id: 3082
Date Added: 8th Jun 2007